Abiopharma

🔍 Sachs Adam David (Director)

Company: Vicarious Surgical Inc. (RBOT)

Report Date: 2025-09-03

Detailed Transactions and Holdings:

• Sold 463 shares of Class A Common Stock at $5.7564 per share (Direct)
  Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,164.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
• F2: This figure is the weighted average sales price of multiple trades ranging from $5.64 to $5.87 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.